𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Refractory ventricular fibrillation complicating acute myocardial infarction terminated by intracoronary stenting

✍ Scribed by Le May, Michel R. ;Higginson, Lyall A.J. ;Tang, Anthony S.L. ;Marquis, Jean-François

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
358 KB
Volume
37
Category
Article
ISSN
0098-6569

No coin nor oath required. For personal study only.

✦ Synopsis

We report on a case of intractable recurrent ventricular fibrillation that responded poorly to antiarrhythmic medication and balloon angioplasty, but resolved instantaneously fol- lowing intracoronary stenting.

📜 SIMILAR VOLUMES

Acute myocardial infarction caused by a
Acute myocardial infarction caused by a myocardial bridge treated with intracoronary stenting
✍ Smith, Stacy C. ;Taber, Mark T. ;Robiolio, Paul A. ;Lasala, John M. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

The clinical significance of myocardial bridges (MBs) is variable, and most patients are asymptomatic. However, angina, myocardial infarction, and sudden death have been reported in association with MBs. Here we describe the use of intracoronary stenting for the treatment of a patient with an anteri

Use of c7E3 Fab in conjunction with prim
Use of c7E3 Fab in conjunction with primary coronary stenting for acute myocardial infarctions complicated by cardiogenic shock
✍ Schultz, Richard D. ;Heuser, Richard R. ;Hatler, Carol ;Frey, Dianne 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 705 KB

Although use of thrombolytic therapy during primary angioplasty is controversial, the development of a monoclonal antibody (c7E3 Fab) to the platelet glycoprotein llblllla receptor has been a tremendous breakthrough in the field of interventional cardiology. Use of the antibody during high-risk angi